Abstract
Background
A diabetic intrauterine environment has been proposed as a potential etiological mechanism for in utero programming of cardiac disease, and is associated with impaired fetal cardiac function. We aimed to assess cardiac function in offspring of mothers with diabetes mellitus (ODM) and determine whether fetal cardiac abnormalities persist during follow-up.
Methods
Longitudinal observational study to evaluate and compare myocardial function in 40 ODM to age-matched control offspring (CO). Myocardial deformation was measured using speckle-tracking echocardiography (STE).
Results
Significant differences were detected in global longitudinal strain (−20.9 ± 3.1 vs. −23.6 ± 2.2%; p = 0.001), global circumferential strain (−24.4 ± 3.9 vs. −26.9 ± 2.7%; p = 0.017), average radial strain (29.0 ± 9.8 vs. 37.1 ± 7.2%; p = 0.003), average longitudinal systolic strain rate (−1.24 ± 0.25/s vs. −1.47 ± 0.30/s; p = 0.011) and average circumferential systolic strain rate (−1.56 ± 0.37/s vs. −1.84 ± 0.37/s; p = 0.013) in comparison to CO up to 2 years of follow-up. Minimal differences were observed within ODM over the 2-year period.
Conclusion
Impaired cardiac function in ODM persists during 2 years follow-up. Functional cardiac assessment might therefore be useful to detect these unfavorable changes, independent of screening for congenital heart disease or hypertrophic cardiomyopathy in this population.
IMPACT
-
We demonstrate persistence of subclinical myocardial deformation abnormalities in offspring of mothers with diabetes mellitus from fetal life to early childhood years.
-
These results extend the cellular observations in basic and translational research of developmental programming into the clinical realm.
-
Persistence of subclinical myocardial deformation abnormalities may shed light on the known incidence of early cardiovascular disease in offspring of mother with diabetes.
-
Cardiac myocardial strain assessment can be useful to detect these abnormalities, independent of screening for congenital heart disease or hypertrophic cardiomyopathy in this population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Chen, L., Magliano, D. J. & Zimmet, P. Z. The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat. Rev. Endocrinol. 8, 228–236 (2011).
Zhou, B. et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 387, 1513–1530 (2016).
Lawrence, J. M. et al. Trends in prevalence of Type 1 and Type 2 diabetes in children and adolescents in the US, 2001-2017. JAMA 326, 717–727 (2021).
Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pr. 183, 109119 (2022).
Lee, A. J., Hiscock, R. J., Wein, P., Walker, S. P. & Permezel, M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30, 878–883 (2007).
Bellamy, L., Casas, J.-P., Hingorani, A. D. & Williams, D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373, 1773–1779 (2009).
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 34, S62-9 (2011).
Zhu, Y. & Zhang, C. Prevalence of gestational diabetes and risk of progression to Type 2 Diabetes: a global perspective. Curr. Diab. Rep. 16, 7 (2016).
Paulo, M. S., Abdo, N. M., Bettencourt-Silva, R. & Al-Rifai, R. H. Gestational Diabetes Mellitus in Europe: A systematic review and meta-analysis of prevalence studies. Front. Endocrinol. 12, 691033 (2021).
Lisowski, L. A. et al. Congenital heart disease in pregnancies complicated by maternal Diabetes Mellitus. Herz 35, 19–26 (2010).
Liu, S. et al. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation 128, 583–589 (2013).
Simeone, R. M. et al. Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project. Am. J. Prev. Med. 48, 195–204 (2015).
Hoang, T. T., Marengo, L. K., Mitchell, L. E., Canfield, M. A. & Agopian, A. J. Original findings and updated meta-analysis for the association between maternal diabetes and risk for congenital heart disease phenotypes. Am. J. Epidemiol. 186, 118–128 (2017).
Helle, E. & Priest, J. R. Maternal obesity and diabetes mellitus as risk factors for congenital heart disease in the offspring. J. Am. Heart Assoc. 9, e011541 (2020).
Wu, Y. et al. Association of maternal prepregnancy diabetes and gestational diabetes mellitus with congenital anomalies of the newborn. Diabetes Care 43, 2983–2990 (2020).
Darwish, A. et al. Fetal echocardiographic parameters in pregnancies complicated by diabetes: a case control study. BMC Pregnancy Childbirth 22, 650 (2022).
Sonaglioni, A. et al. Comprehensive assessment of biventricular myocardial function by two-dimensional speckle tracking echocardiography in infants of gestational diabetic mothers. Acta Diabetol. 59, 1145–1156 (2022).
Hatém, M. A. B. et al. Assessment of diastolic ventricular function in fetuses of diabetic mothers using tissue Doppler. Cardiol. Young-. 18, 297–302 (2008).
Pilania, R., Sikka, P., Rohit, M. K., Suri, V. & Kumar, P. Fetal Cardiodynamics by Echocardiography in insulin dependent maternal diabetes and its correlation with pregnancy outcome. J. Clin. Diagn. Res. 10, QC01-4 (2016).
Bhorat, I., Pillay, M. & Reddy, T. Determination of the fetal myocardial performance index in women with gestational impaired glucose tolerance and to assess whether this parameter is a possible prognostic indicator of adverse fetal outcome. J. Matern. Fetal Neonatal Med. 31, 2019–2026 (2018).
Bhorat, I., Pillay, M. & Reddy, T. Assessment of the fetal myocardial performance index in well-controlled gestational diabetics and to determine whether it is predictive of adverse perinatal outcome. Pediatr. Cardiol. 40, 1460–1467 (2019).
Özalp, M. et al. Fetal cardiac Doppler changes in gestational diabetic pregnancies and its relationship with perinatal outcomes. J. Obstet. Gynaecol. Res. 47, 3480–3487 (2021).
Mor-Avi, V. et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur. J. Echocardiogr. J. Work. Gr. Echocardiogr. Eur. Soc. Cardiol. 12, 167–205 (2011).
Ohira, A. et al. The assessment of the fetal heart function using two-dimensional speckle tracking with a high frame rate. Early Hum. Dev. 151, 105160 (2020).
van Oostrum, N. H. M. et al. Fetal myocardial deformation measured with two-dimensional speckle-tracking echocardiography: longitudinal prospective cohort study of 124 healthy fetuses. Ultrasound Obstet. Gynecol. 59, 651–659 (2022).
Crispi, F. et al. Feasibility and reproducibility of a standard protocol for 2D Speckle tracking and tissue doppler-based strain and strain rate analysis of the fetal heart. Fetal Diagn. Ther. 32, 96–108 (2012).
Song, X. et al. Ventricular myocardial deformation in fetuses with tetralogy of fallot: A necessary field of investigation. Front. Cardiovasc. Med. 8, 764676 (2021).
van Oostrum, N. H. M. et al. Two-dimensional Speckle tracking echocardiography in Fetal Growth Restriction: a systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 254, 87–94 (2020).
Patey, O., Carvalho, J. S. & Thilaganathan, B. Perinatal changes in fetal cardiac geometry and function in diabetic pregnancy at term. J. Int. Soc. Ultrasound Obstet. Gynecol. 54, 634–642 (2019).
Cade, W. T. et al. Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes. Pediatr. Res. 82, 768–775 (2017).
Aguilera, J. et al. Cardiac function in gestational diabetes mellitus: A longitudinal study from fetal life to infancy. BJOG 128, 272–279 (2021).
Kulkarni, A. et al. Fetal myocardial deformation in maternal diabetes mellitus and obesity. Ultrasound Obstet. Gynecol. 49, 630–636 (2017).
Firpo, C., Hoffman, J. I. & Silverman, N. H. Evaluation of fetal heart dimensions from 12 weeks to term. Am. J. Cardiol. 87, 594–600 (2001).
Rychik, J. et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J. Am. Soc. Echocardiogr. 17, 803–810 (2004).
Voigt, J.-U. et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J. Am. Soc. Echocardiogr. Publ. Am. Soc. Echocardiogr. 28, 183–193 (2015).
Depla, A. L. et al. Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 57, 539–550 (2021).
Chu, C., Gui, Y. H., Ren, Y. Y. & Shi, L. Y. The impacts of maternal gestational diabetes mellitus (GDM) on fetal hearts. Biomed. Environ. Sci. 25, 15–22 (2012).
Garcia-Flores, J. et al. Fetal myocardial morphological and functional changes associated with well-controlled gestational diabetes. Eur. J. Obstet. Gynecol. Reprod. Biol. 154, 24–26 (2011).
Wang, H., Xu, Y., Fu, J. & Huang, L. Evaluation of the regional ventricular systolic function by two-dimensional strain echocardiography in gestational diabetes mellitus (GDM) fetuses with good glycemic control. J. Matern. Neonatal Med. 28, 2150–2154 (2015).
Miranda, J. O., Cerqueira, R. J., Ramalho, C., Areias, J. C. & Henriques-Coelho, T. Fetal cardiac function in maternal diabetes: A conventional and speckle-tracking Echocardiographic Study. J. Am. Soc. Echocardiogr. 31, 333–341 (2018).
Hoodbhoy, Z. et al. Is the child at risk? Cardiovascular remodelling in children born to diabetic mothers. Cardiol. Young-. 29, 467–474 (2019).
Yu, Y. et al. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. BMJ 367, l6398 (2019).
Nakano, H. et al. Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. eLife 6, e29330 (2017).
Reinking, B. E., Wedemeyer, E. W., Weiss, R. M., Segar, J. L. & Scholz, T. D. Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways. Cardiovasc. Diabetol. 8, 43 (2009).
Kopylov, A. T. et al. Severe types of fetopathy are associated with changes in the serological proteome of diabetic mothers. Medicine 100, e27829 (2021).
Mdaki, K. S. et al. Maternal high-fat diet impairs cardiac function in offspring of diabetic pregnancy through metabolic stress and mitochondrial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 310, H681–92 (2016).
Upadhyaya, B. et al. Prenatal exposure to a maternal high-fat diet affects histone modification of cardiometabolic genes in newborn rats. Nutrients 9, 407 (2017).
Nelson, S. M., Sattar, N., Freeman, D. J., Walker, J. D. & Lindsay, R. S. Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes 56, 2697–2704 (2007).
Turan, S. et al. Decreased fetal cardiac performance in the first trimester correlates with hyperglycemia in pregestational maternal diabetes. Ultrasound Obstet. Gynecol. 38, 325–331 (2011).
Al-Biltagi, M., Tolba, O. A. R. E., Rowisha, M. A., Mahfouz, A. E.-S. & Elewa, M. A. Speckle tracking and myocardial tissue imaging in infant of diabetic mother with gestational and pregestational diabetes. Pediatr. Cardiol. 36, 445–453 (2015).
Litwin, L. et al. No effect of gestational diabetes or pre-gestational obesity on 6-year offspring left ventricular function-RADIEL study follow-up. Acta Diabetol. 57, 1463–1472 (2020).
Acknowledgements
The authors would like to thank Ling Li (LL), MD, PhD from University of Nebraska Medical Center, Omaha, NE and Daisy Gonzalez (DG), RDCS from White Plains Hospital, NY for their efforts in data measurements and data collection.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Xander Jacquemyn was supported by the Belgian American Educational Foundation.
Author information
Authors and Affiliations
Contributions
X.J.: Concept/design, data collection, data interpretation, drafting article, critical revision of article, and approval of article. S.K.: Concept/design, data interpretation, drafting article, critical revision of article, and approval of article. P.D.: Data interpretation, drafting article, critical revision of article, and approval of article. W.J.R.: Data interpretation, drafting article, critical revision of article, and approval of article. A.K.: Concept/design, data collection, data interpretation, drafting article, critical revision of article, and approval of article.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Consent statement
All participants included in this study gave informed consent for inclusion at the time of enrollment and at follow-up at 1- and 2 years respectively.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jacquemyn, X., Kutty, S., Dhanantwari, P. et al. Impaired myocardial deformation persists at 2 years in offspring of mothers with diabetes mellitus. Pediatr Res 94, 996–1002 (2023). https://doi.org/10.1038/s41390-023-02566-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-02566-6